ChinaAMC Direxion NASDAQ-100 Daily (-1x) Inverse Product
ChinaAMC Direxion NASDAQ-100 Daily (-1x) Inverse Product Fundamental Analysis
ChinaAMC Direxion NASDAQ-100 Daily (-1x) Inverse Product (7331.HK) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 7331.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak7331.HK struggles to generate sufficient returns from assets.
Valuation Score
Weak7331.HK trades at a premium to fair value.
Growth Score
Weak7331.HK faces weak or negative growth trends.
Financial Health Score
Weak7331.HK carries high financial risk with limited liquidity.
Profitability Score
Weak7331.HK struggles to sustain strong margins.
Key Financial Metrics
Is 7331.HK Expensive or Cheap?
No data available.
How Well Does 7331.HK Make Money?
No data available.
Following the Money - Real Cash Generation
No data available.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
N/A
vs 25 benchmark
Current Ratio
Current assets to current liabilities
N/A
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
N/A
vs 25 benchmark
ROA
Return on assets percentage
N/A
vs 25 benchmark
ROCE
Return on capital employed
N/A
vs 25 benchmark
How 7331.HK Stacks Against Its Sector Peers
| Metric | 7331.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 19.02 | N/A |
| ROE | N/A | 815.00% | N/A |
| Net Margin | N/A | 1816.00% | N/A |
| Debt/Equity | N/A | 0.98 | N/A |
| Current Ratio | N/A | 670.62 | N/A |
| ROA | N/A | -24633.00% (disorted) | N/A |
Historical Growth Performance
5-Year Growth Trajectory
This section reviews ChinaAMC Direxion NASDAQ-100 Daily (-1x) Inverse Product's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical